SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $93 | -94.8% | 811 | -93.8% | 0.02% | -97.1% |
| Q1 2023 | $1,792 | -99.9% | 13,000 | -48.0% | 0.77% | -20.1% |
| Q4 2021 | $2,251,000 | +15.8% | 25,000 | 0.0% | 0.96% | +153.7% |
| Q2 2021 | $1,944,000 | +30.4% | 25,000 | +25.0% | 0.38% | -30.1% |
| Q1 2021 | $1,491,000 | -48.6% | 20,000 | -11.1% | 0.54% | -49.5% |
| Q4 2019 | $2,903,000 | +156.9% | 22,500 | +50.0% | 1.08% | +89.1% |
| Q3 2019 | $1,130,000 | -73.0% | 15,000 | -45.5% | 0.57% | -43.6% |
| Q2 2019 | $4,179,000 | +133.7% | 27,500 | +83.3% | 1.01% | +53.4% |
| Q1 2019 | $1,788,000 | -18.1% | 15,000 | -25.0% | 0.66% | -44.0% |
| Q4 2018 | $2,183,000 | -45.9% | 20,000 | -20.0% | 1.18% | -18.3% |
| Q3 2018 | $4,038,000 | +1.8% | 25,000 | -16.7% | 1.44% | -5.5% |
| Q2 2018 | $3,965,000 | +78.4% | 30,000 | 0.0% | 1.52% | +47.1% |
| Q1 2018 | $2,223,000 | +33.2% | 30,000 | 0.0% | 1.04% | +67.5% |
| Q4 2017 | $1,669,000 | – | 30,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,999,453 | $413,414,607 | 13.31% |
| Casdin Capital, LLC | 1,160,000 | $159,882,800 | 13.17% |
| Ikarian Capital, LLC | 271,300 | $37,393,279 | 8.48% |
| Avoro Capital Advisors LLC | 3,650,000 | $503,079,500 | 7.46% |
| Evolutionary Tree Capital Management, LLC | 36,190 | $4,988,068 | 6.91% |
| Finepoint Capital LP | 122,757 | $16,919,597 | 6.46% |
| Ikarian Capital, LLC | 205,400 | $28,310,282 | 6.42% |
| Boxer Capital, LLC | 775,000 | $106,818 | 5.25% |
| Ghost Tree Capital, LLC | 125,000 | $17,229,000 | 5.09% |
| Logos Global Management LP | 220,000 | $30,322,600 | 4.34% |